Latest Board And Management Changes News

Altech Batteries Limited has undergone a significant board and management reshuffle following a shareholder-led challenge, appointing new leadership while reaffirming its strategic focus on advanced battery technologies.

Avenira Limited reports significant progress at its Wonarah Phosphate Project, alongside key board and management changes, while maintaining a solid cash position at the end of Q3 2025.

Artemis Resources has reported promising early drilling results at its Karratha Gold-Copper Project alongside key tenement grants and agreements at its Cassowary Exploration Project, supported by a recent $4.9 million capital raise.

Tamboran Resources has reported record natural gas flow rates from its Shenandoah South 2H sidetrack well and initiated the largest drilling program ever seen in the Beetaloo Basin, alongside securing key approvals for gas sales.

Following its recent sale transaction, MPR Australia Limited announces significant board resignations alongside continued leadership under CEO Nathan Wise, signaling a strategic transition phase.

NeuroScientific Biopharmaceuticals reported a $1.85 million loss for FY25, driven by reduced R&D incentives and increased development costs following its acquisition of StemSmart™ technology. The company is advancing clinical programs, including a Special Access Scheme for Crohn’s disease.

Bastion Minerals has resumed ASX trading under a refreshed leadership team, announcing a JORC-compliant resource at its ICE Copper-Gold Project and completing multiple capital raises to support its renewed exploration focus.

Oceana Lithium Limited advanced its lithium, uranium, and base metals exploration across Australia and Brazil in the June 2025 quarter, supported by a $667,000 capital raise and key board appointments.

Following its merger with IDM International, Blackstone Minerals announces key board and management changes to spearhead development of the Mankayan Copper-Gold Project in the Philippines.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Wellnex Life Limited announces key board and management changes following its successful AIM Market dual listing, including the resignation of its Non-Executive Chairman and appointment of a joint CEO to drive growth.

ENRG Elements Limited has completed a strategic overhaul with new management, significant cost reductions, and a renewed focus on its Agadez Uranium Project, while exiting several lithium assets.